Becton Dickinson (BDX): are the analysts right?

Becton Dickinson · Health Care · ref. ETF XLV · 50 calls · price $156.3
What the company does: Becton Dickinson fabrique des fournitures médicales, équipements de diagnostic et dispositifs.
📈 1-year price
$156.3+13.8% over range
Jul 8, 25low $135.54 · high $185.39Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
50% recommend buying · 10 analysts

🎯 Analyst price target on BDX

High target · 2 analysts$204+30.5%
Median target · 10 analysts$177.5+13.6%
Low target · 3 analysts$159+1.7%
Current price$156.3

🗳️ The analyst consensus

Analyst breakdown · 10 (6 months)
Strong Buy0%
Buy50%
Hold50%
Sell0%
Strong Sell0%

💰 Becton Dickinson dividend

2.45%annual yield
🏆 Aristocrat28 yrs of consecutive dividend increases
That's ~$3.74 per share per year.

✅ Historical analyst reliability on BDX

Most reliable analysts on BDX (% profitable · 365j · ≥2 calls)
Morgan Stanley 50% +4.9% 2
Citigroup 50% -4.9% 2
Barclays 50% -5.2% 6
Stifel 50% -5.8% 2
Piper Sandler 0% -8.3% 3
Raymond James 0% -10.0% 3
Evercore ISI Group 0% -21.6% 2

📊 What $1,000 invested in Becton Dickinson would be worth

In short — $1,000 invested in Becton Dickinson 10 years ago would be worth $1,357 today, i.e. +3%/yr on average. Best year: 2017 (+37%), worst: 2025 (-18%). Price performance, excluding dividends.

If I'd invested $1,000 in Becton Dickinson

InvestmentWorth todayGain
1 years ago$777-22%
3 years ago$763-24%
5 years ago$754-25%
10 years ago$1,357+36%
since inception (1973)$86,489+8549%

Return by year (Becton Dickinson)

YearReturn$1,000 invested at year start
2026 (YTD)-5%$946 (-5%)
2025-18%$777 (-22%)
2024+4%$806 (-19%)
2023-5%$763 (-24%)
2022+2%$776 (-22%)
2021-3%$754 (-25%)
2020-5%$717 (-28%)
2019+10%$791 (-21%)
2018+3%$812 (-19%)
2017+37%$1,113 (+11%)
2016+22%$1,357 (+36%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance💰 Dividend
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on BDX

▲ Outperform · 🎯$180
Price at call : $156.3 — upside +15%
Today : $156.3 — upside +15%
🎯 on BDX : 0% (2 calls matureds) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Jul 6, 27
Barclays
May 11, 26
▲ Overweight · 🎯$204
Price at call : $143.15 — upside +43%
Today : $156.3 — upside +31%
🎯 on BDX : 50% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : May 11, 27
Wells Fargo
May 8, 26
■ Equal-Weight neutral · not a buy · 🎯$161
Price at call : $149.43 — gap to target +8%
Today : $156.3 — gap to target +3%
🎯 on BDX : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : May 8, 27
TD Cowen
May 4, 26
■ Hold neutral · not a buy · 🎯$163
Price at call : $144.17 — gap to target +13%
Today : $156.3 — gap to target +4%
🎯 on BDX : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : May 4, 27
Piper Sandler
Apr 17, 26
■ Neutral neutral · not a buy · 🎯$159
Price at call : $158.64 — gap to target +0%
Today : $156.3 — gap to target +2%
🎯 on BDX : 0% (3 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Apr 17, 27
▲ Buy · 🎯$180
Price at call : $155.92 — upside +15%
Today : $156.3 — upside +15%
🎯 on BDX : no call matured yet · 📊 on Health : 56.4% · +2.9% (156 calls)
in progress (365j)
matures : Mar 23, 27
Citigroup
Feb 11, 26
▲ Buy · 🎯$198
Price at call : $177.81 — upside +11%
Today : $156.3 — upside +27%
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Feb 11, 27
JP Morgan
Feb 10, 26
■ Neutral neutral · not a buy · 🎯$175
Price at call : $180.62 — gap to target -3%
Today : $156.3 — gap to target +12%
🎯 on BDX : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Feb 10, 27
Jefferies
Feb 10, 26
▲ Buy · 🎯$190
Price at call : $180.62 — upside +5%
Today : $156.3 — upside +22%
🎯 on BDX : no call matured yet · 📊 on Health : 50.5% · +4.5% (376 calls)
in progress (365j)
matures : Feb 10, 27
RBC Capital
Feb 10, 26
■ Sector Perform neutral · not a buy · 🎯$172
Price at call : $180.62 — gap to target -5%
Today : $156.3 — gap to target +10%
🎯 on BDX : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Feb 10, 27
Citigroup
Feb 10, 26
▲ Buy · 🎯$232
Price at call : $180.62 — upside +28%
Today : $156.3 — upside +48%
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Feb 10, 27
Piper Sandler
Feb 10, 26
■ Neutral neutral · not a buy · 🎯$170
Price at call : $180.62 — gap to target -6%
Today : $156.3 — gap to target +9%
🎯 on BDX : 0% (3 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Feb 10, 27
Wells Fargo
Feb 10, 26
■ Equal-Weight neutral · not a buy · 🎯$157
Price at call : $171.68 — gap to target -9%
Today : $156.3 — gap to target +0%
🎯 on BDX : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Feb 10, 27
Piper Sandler
Jan 28, 26
■ Neutral neutral · not a buy · 🎯$205
Price at call : $158.74 — gap to target +29%
Today : $156.3 — gap to target +31%
🎯 on BDX : 0% (3 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Jan 28, 27
Stifel
Jan 7, 26
▲ Buy · 🎯$215
Price at call : $159.36 — upside +35%
Today : $156.3 — upside +38%
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 51.2% · +8.2% (297 calls)
in progress (365j)
matures : Jan 7, 27
■ Neutral neutral · not a buy · 🎯$207
Price at call : $156.42 — gap to target +32%
Today : $156.3 — gap to target +32%
🎯 on BDX : no call matured yet · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Jan 5, 27
RBC Capital
Dec 17, 25
■ Sector Perform neutral · not a buy · 🎯$210
Price at call : $153.58 — gap to target +37%
Today : $156.3 — gap to target +34%
🎯 on BDX : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Dec 17, 26
▲ Overweight · 🎯$210
Price at call : $152.18 — upside +38%
Today : $156.3 — upside +34%
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Dec 2, 26
RBC Capital
Nov 7, 25
■ Sector Perform neutral · not a buy · 🎯$202
Price at call : $142.8 — gap to target +41%
Today : $156.3 — gap to target +29%
🎯 on BDX : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Nov 7, 26
■ Neutral neutral · not a buy · 🎯$190
Price at call : $139.81 — gap to target +36%
Today : $156.3 — gap to target +22%
🎯 on BDX : 0% (3 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Nov 7, 26
RBC Capital
Oct 16, 25
■ Sector Perform neutral · not a buy · 🎯$211
Price at call : $148.66 — gap to target +42%
Today : $156.3 — gap to target +35%
🎯 on BDX : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Oct 16, 26
RBC Capital
Sep 25, 25
■ Sector Perform neutral · not a buy · 🎯$211
Price at call : $141.97 — gap to target +49%
Today : $156.3 — gap to target +35%
🎯 on BDX : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Sep 25, 26
▲ Overweight · 🎯$197
Price at call : $153.27 — upside +29%
Today : $156.3 — upside +26%
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Aug 11, 26
Wells Fargo
Aug 8, 25
■ Equal-Weight neutral · not a buy · 🎯$184
Price at call : $151.34 — gap to target +22%
Today : $156.3 — gap to target +18%
🎯 on BDX : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Aug 8, 26
■ Neutral neutral · not a buy · 🎯$200
Price at call : $152.12 — gap to target +31%
Today : $156.3 — gap to target +28%
🎯 on BDX : 0% (3 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Aug 8, 26
Barclays
Jun 3, 25
▲ Overweight · 🎯$241
Price at call : $134.17 — upside +80%
Today : $156.3 — upside +54%
Expected +80% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
+8.5%
stock +9% · XLV +11%
Citigroup
May 22, 25
■ Neutral neutral · not a buy · 🎯$185
Price at call : $135.46 — gap to target +37%
Today : $156.3 — gap to target +18%
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : May 22, 26
▲ Overweight · 🎯$196
Price at call : $131.4 — upside +49%
Today : $156.3 — upside +25%
Expected +49% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
+16.6%
stock +17% · XLV +7%
■ Neutral neutral · not a buy · 🎯$185
Price at call : $131.29 — gap to target +41%
Today : $156.3 — gap to target +18%
🎯 on BDX : 0% (3 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : May 2, 26
Stifel
May 2, 25
▲ Buy · 🎯$224
Price at call : $131.29 — upside +71%
Today : $156.3 — upside +43%
Expected +71% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 51.2% · +8.2% (297 calls)
+11.4%
stock +11% · XLV +5%
■ Market Perform neutral · not a buy
🎯 on BDX : no call matured yet · 📊 on Health : 65.4% · +5.6% (26 calls)
in progress (365j)
matures : May 2, 26
Citigroup
May 1, 25
▲ Buy · 🎯$217
Price at call : $132.69 — upside +64%
Today : $156.3 — upside +39%
Expected +64% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
+10.3%
stock +10% · XLV +4%
Piper Sandler
Apr 23, 25
▲ Overweight · 🎯$260
Price at call : $160.73 — upside +62%
Today : $156.3 — upside +66%
Expected +62% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 0% (3 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
-5.3%
stock -5% · XLV +5%
Barclays
Apr 7, 25
▲ Overweight · 🎯$261
Price at call : $157.89 — upside +65%
Today : $156.3 — upside +67%
Expected +65% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-0.5%
stock -1% · XLV +13%
Barclays
Feb 14, 25
▲ Overweight · 🎯$279
Price at call : $176.73 — upside +58%
Today : $156.3 — upside +79%
Expected +58% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
+0.4%
stock +0% · XLV +9%
Piper Sandler
Jan 28, 25
▲ Overweight · 🎯$280
Price at call : $195.82 — upside +43%
Today : $156.3 — upside +79%
Expected +43% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 0% (3 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
-18.9%
stock -19% · XLV +5%
Barclays
Jan 22, 25
▲ Overweight · 🎯$278
Price at call : $187.04 — upside +49%
Today : $156.3 — upside +78%
Expected +49% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-13.4%
stock -13% · XLV +11%
▲ Outperform · 🎯$290
Price at call : $188.49 — upside +54%
Today : $156.3 — upside +86%
Expected +54% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 0% (2 calls matureds) · 📊 on Health : 47.6% · +1.3% (147 calls)
-20.1%
stock -20% · XLV -6%
Citigroup
Oct 1, 24
▲ Buy · 🎯$275
Price at call : $188.49 — upside +46%
Today : $156.3 — upside +76%
Expected +46% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
-20.1%
stock -20% · XLV -6%
▲ Outperform · 🎯$270
Price at call : $185.36 — upside +46%
Today : $156.3 — upside +73%
Expected +46% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 0% (3 calls matureds) · 📊 on Health : 46.8% · +2.0% (395 calls)
-24.1%
stock -24% · XLV -9%
Stifel
Jul 26, 24
▲ Buy · 🎯$280
Price at call : $186.98 — upside +50%
Today : $156.3 — upside +79%
Expected +50% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 51.2% · +8.2% (297 calls)
-23.1%
stock -23% · XLV -10%
Citigroup
Jul 11, 24
■ Neutral neutral · not a buy · 🎯$255
Price at call : $176.84 — gap to target +44%
Today : $156.3 — gap to target +63%
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Jul 11, 25
▲ Outperform · 🎯$285
Price at call : $179.91 — upside +58%
Today : $156.3 — upside +82%
Expected +58% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 0% (2 calls matureds) · 📊 on Health : 47.6% · +1.3% (147 calls)
-23.0%
stock -23% · XLV -5%
Goldman Sachs
May 30, 24
▲ Buy · 🎯$274
Price at call : $178.29 — upside +54%
Today : $156.3 — upside +75%
Expected +54% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 0% (1 call matured) · 📊 on Health : 50.8% · +2.0% (240 calls)
-23.9%
stock -24% · XLV -6%
Barclays
May 6, 24
▲ Overweight · 🎯$312
Price at call : $186.44 — upside +67%
Today : $156.3 — upside +100%
Expected +67% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
-29.5%
stock -30% · XLV -5%
Barclays
Feb 5, 24
▲ Overweight · 🎯$305
Price at call : $184.8 — upside +65%
Today : $156.3 — upside +95%
Expected +65% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (6 calls matureds) · 📊 on Health : 50.1% · +2.2% (617 calls)
+3.1%
stock +3% · XLV +3%
▲ Outperform · 🎯$275
Price at call : $190.97 — upside +44%
Today : $156.3 — upside +76%
Expected +44% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 0% (3 calls matureds) · 📊 on Health : 46.8% · +2.0% (395 calls)
-5.9%
stock -6% · XLV -0%
▲ Overweight · 🎯$280
Price at call : $186.77 — upside +50%
Today : $156.3 — upside +79%
Expected +50% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
-6.9%
stock -7% · XLV +11%
Piper Sandler
Nov 10, 23
▲ Overweight · 🎯$280
Price at call : $185.42 — upside +51%
Today : $156.3 — upside +79%
Expected +51% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 0% (3 calls matureds) · 📊 on Health : 47% · -1.0% (313 calls)
-0.5%
stock -1% · XLV +18%
Raymond James
Nov 10, 23
▲ Outperform · 🎯$269
Price at call : $184.47 — upside +46%
Today : $156.3 — upside +72%
Expected +46% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 0% (3 calls matureds) · 📊 on Health : 46.8% · +2.0% (395 calls)
-0.0%
stock -0% · XLV +18%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)